As their use grows, many people are wondering if they are safe after breast cancer, whether they might influence cancer outcomes and not just weight, and what researchers are currently studying to help answer those questions
Influx of positively charged ions into the postsynaptic neuron can have excitatory effects by depolarizing the membrane
The slowed gastric emptying means large meals sit uncomfortably
For Medical Affairs teams, the focus now shifts to real-world evidence, physician education, patient adherence, and pharmacoeconomic value storytelling
A: FDA-approved medications have undergone rigorous testing for safety, efficacy, and quality
Important advice for users of GLP-1 medications and weight-loss peptides You must notify your anaesthetist or the hospital pre-admission clinic as soon as possible if you use any GLP-1 diabetic or weight-loss medications, including: Ozempic / Wegovy (Semaglutide) Mounjaro (Tirzepatide) Trulicity (Dulaglutide) Victoza / Saxenda (Liraglutide) You must tell your anaesthetist if you use peptide products for weight loss, in particular products that are labelled: Retatrutide, Reta, R-10, R-20
